Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Pharmaxis Ltd ( (AU:SNT) ) has issued an announcement.
Syntara Limited reported a significant increase in revenues from ordinary activities and other income for the half-year ended 31 December 2024, with a 337.94% rise to $3,070,000. The company also reported a substantial reduction in its loss from ordinary activities after tax, which decreased by 54.3% to $2,716,000 compared to the previous period. Despite the improved financial performance, no dividends were declared or paid during the current financial period.
More about Pharmaxis Ltd
YTD Price Performance: -2.50%
Average Trading Volume: 5,587,286
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$126.6M
Find detailed analytics on SNT stock on TipRanks’ Stock Analysis page.